Literature DB >> 11516061

A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection.

D Warren1, R S Klein, J Sobel, B Kieke, W Brown, P Schuman, J Anderson, S Cu-Uvin, K Mayer, D J Jamieson, S Holmberg, A Duerr.   

Abstract

BACKGROUND: Bacterial vaginosis is a common gynecologic infection that has been associated with a variety of gynecologic and obstetric complications, including pelvic inflammatory disease, postabortal infection and premature delivery. Recent studies suggest that bacterial vaginosis may increase a woman's risk for human immunodeficiency virus (HIV). We undertook this study to assess whether the prevalence and characteristics of bacterial vaginosis differed according to HIV status in high-risk US women.
METHODS: Prevalence of bacterial vaginosis was assessed by Gram's stain and clinical criteria for 854 HIV-infected and 434 HIV-uninfected women enrolled in the HIV Epidemiology Research (HER) Study. Multiple logistic regression techniques were used to determine whether HIV infection independently predicted bacterial vaginosis.
RESULTS: Almost half (46%) the women had bacterial vaginosis by Gram's stain. The prevalence of bacterial vaginosis was 47% in the HIV-positive women compared with 44% in the HIV-negative women; this difference was not statistically significant (p = 0.36). After adjustment for other covariates, HIV-positive women were more likely than HIV-negative women to have bacterial vaginosis (odds ratio (OR) 1.31; 95% confidence interval (CI) 1.01-1.70) by Gram's stain but not by clinical criteria (OR 1.16; CI 0.87-1.55). Among HIV-positive women, use of antiretroviral drugs was associated with a lower prevalence of bacterial vaginosis (adjusted OR 0.54; Cl 0.38-0.77).
CONCLUSIONS: In this cross-sectional analysis of high-risk US women, HIV infection was positively correlated with bacterial vaginosis diagnosed by Gram's stain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516061      PMCID: PMC1784649          DOI: 10.1155/S1064744901000242

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  29 in total

Review 1.  Pelvic inflammatory disease. A brief overview.

Authors:  N S Padian; A E Washington
Journal:  Ann Epidemiol       Date:  1994-03       Impact factor: 3.797

Review 2.  Role of bacterial vaginosis in pelvic inflammatory disease.

Authors:  R L Sweet
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

3.  The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women.

Authors:  S L Hillier; M A Krohn; L K Rabe; S J Klebanoff; D A Eschenbach
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

4.  Inactivation of human immunodeficiency virus type 1 by the amine oxidase-peroxidase system.

Authors:  S J Klebanoff; F Kazazi
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

Review 5.  Chorioamnionitis and bacterial vaginosis.

Authors:  R S Gibbs
Journal:  Am J Obstet Gynecol       Date:  1993-08       Impact factor: 8.661

Review 6.  Diagnostic microbiology of bacterial vaginosis.

Authors:  S L Hillier
Journal:  Am J Obstet Gynecol       Date:  1993-08       Impact factor: 8.661

7.  Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand.

Authors:  C R Cohen; A Duerr; N Pruithithada; S Rugpao; S Hillier; P Garcia; K Nelson
Journal:  AIDS       Date:  1995-09       Impact factor: 4.177

8.  Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study.

Authors:  P G Larsson; J J Platz-Christensen; H Thejls; U Forsum; C Påhlson
Journal:  Am J Obstet Gynecol       Date:  1992-01       Impact factor: 8.661

9.  Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.

Authors:  J C Hauth; R L Goldenberg; W W Andrews; M B DuBard; R L Copper
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

10.  The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Authors:  P J Meis; R L Goldenberg; B Mercer; A Moawad; A Das; D McNellis; F Johnson; J D Iams; E Thom; W W Andrews
Journal:  Am J Obstet Gynecol       Date:  1995-10       Impact factor: 8.661

View more
  17 in total

Review 1.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.

Authors:  Julius Atashili; Charles Poole; Peter M Ndumbe; Adaora A Adimora; Jennifer S Smith
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

Review 2.  Vaginal microbiota and susceptibility to HIV.

Authors:  McKenna C Eastment; R Scott McClelland
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

3.  Lower Genital Tract Infections in HIV-Infected Women: Can We Afford to Miss?

Authors:  Meenakshi Lallar; Smiti Nanda; Rajesh Nandal
Journal:  J Obstet Gynaecol India       Date:  2014-09-21

4.  Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.

Authors:  Megan Gatski; David H Martin; Rebecca A Clark; Emily Harville; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2011-03       Impact factor: 2.830

5.  Use of species-directed 16S rRNA gene PCR primers for detection of Atopobium vaginae in patients with bacterial vaginosis.

Authors:  Michael J Ferris; Alicia Masztal; David H Martin
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

6.  HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women.

Authors:  Jonathan A Cohn; Farhad B Hashemi; Margaret Camarca; Fanhui Kong; Jiahong Xu; Suzanne K Beckner; Andrea A Kovacs; Patricia S Reichelderfer; Gregory T Spear
Journal:  J Acquir Immune Defic Syndr       Date:  2005-07-01       Impact factor: 3.731

7.  Purification and characterization of enterocin 62-6, a two-peptide bacteriocin produced by a vaginal strain of Enterococcus faecium: Potential significance in bacterial vaginosis.

Authors:  Diane C Dezwaan; Michael J Mequio; Julia S Littell; Jonathan P Allen; Silvia Rossbach; Vivien Pybus
Journal:  Microb Ecol Health Dis       Date:  2007-07-30

Review 8.  Pregnancy in HIV-positive patients: effects on vaginal flora.

Authors:  Cristina Vallone; Giuliano Rigon; Valeria Lucantoni; Lorenza Putignani; Fabrizio Signore
Journal:  Infect Dis Obstet Gynecol       Date:  2012-05-17

9.  Lower genital tract infections in HIV-seropositive women in India.

Authors:  Vandana Goel; P Bhalla; Abha Sharma; Y M Mala
Journal:  Indian J Sex Transm Dis AIDS       Date:  2011-07

10.  Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by Enterococcus faecium 62-6: potential significance for bacterial vaginosis.

Authors:  Maureen C Kelly; Michael J Mequio; Vivien Pybus
Journal:  Infect Dis Obstet Gynecol       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.